Broodkruimel

null

COMPAR-EU RCTs Web

Impact of pharmaceutical care in clinical outcomes and quality of life of patients with type 2 diabetes mellitus

Author: Maidana, G. M. Country/countries: N/A Number of patients participating in the study: 64 This study was focused on patients living with Type 2 Diabetes Mellitus
Intervention analysed in the study: Usual Care Plus Intervention components: UCP
See more
Setting of implementation: N/A Professionals delivering the intervention: N/A Targeted self-management behaviours: N/A
Intervention analysed in the study: Education based intervention Intervention components: E
See more
Setting of implementation: Primary care centers (GPs) Professionals delivering the intervention: Pharmacists Targeted self-management behaviours: Eating behaviours, Medication use and adherence

Outcomes measured in the study

uitkomst maat Tool
HbA1C Glycated hemoglobin (HbA1c) N/A
Quality of life Quality of life N/A

Patient characteristics

Age: 55.6 years (+/- a standard deviation of 10.6) Gender: 72.0% female Time since diagnosis of Type 2 Diabetes Mellitus: N/A Severity of the disease: 8.55 (+/- a standard deviation of 1.86) Multi-morbidity: N/A
  • Number of co-morbidities: N/A

Level of health literacy: N/A
  • Tool: N/A

Socio-economic characteristics: N/A

Risk of Bias of this study

uitkomst Random sequence generation Allocation concealment Blinding performance Blinding detection objective outcomes assessment Attrition incomplete outcome Incorrect statistical methods Recruitment bias Selective outcome reporting
HbA1C - Glycated hemoglobin (HbA1c)
Quality of life - Quality of life